氟康唑
材料科学
真菌性角膜炎
角膜炎
抗真菌
纳米技术
包裹体(矿物)
生物医学工程
皮肤病科
医学
性别研究
社会学
作者
Ulfah Mahfufah,Muhammad Alif Sya’ban Mahfud,Mesakh Diki Saputra,Sumayya Binti Abd Azis,Azimah Salsabila,Rangga Meidianto Asri,Habibie Habibie,Yessie Widya Sari,Risfah Yulianty,Ahmad R. Alsayed,Boonnada Pamornpathomkul,Maria Mir,Andi Dian Permana
标识
DOI:10.1021/acsami.3c19482
摘要
Fluconazole (FNL) is one of the first-line treatments for fungal keratitis as it is an effective broad-spectrum antimicrobial commonly administered orally or topically. However, FNL has a very low water solubility, limiting its drug formulation, therapeutic application, and bioavailability through tissues. To overcome these limitations, this study aimed to develop FNL inclusion complexes (FNL-IC) with cyclodextrin (α-cyclodextrin, sulfobutylether-β-cyclodextrin, and hydroxypropyl-γ cyclodextrin) and incorporate it into a dissolvable microneedle (DMN) system to improve solubility and drug penetration. FNL-IC was evaluated for saturation solubility, Fourier transform infrared spectroscopy, differential scanning calorimetry, in vitro release, minimum inhibitory concentration, minimum fungicidal concentration, and time-killing assay. DMN-FNL-IC was evaluated for mechanical and insertion properties, surface pH, moisture absorption ability, water vapor transmission, and drug content recovery. Moreover, ocular kinetic, ex vivo antimicrobial, in vivo antifungal, and chorioallantoic membrane (HET-CAM) assays were conducted to assess the overall performance of the formulation. Mechanical strength and insertion properties revealed that DMN-FNL-IC has great mechanical and insertion properties. The in vitro release of FNL-IC was significantly improved, exhibiting a 9-fold increase compared to pure FNL. The ex vivo antifungal activity showed significant inhibition of
科研通智能强力驱动
Strongly Powered by AbleSci AI